What a difference a year makes.

In August 2017, Johnson & Johnson chief executive Alex Gorsky criticized President Trump and resigned from a White House manufacturing advisory council after Trump caused outrage with his response to violence at a Charlottesville, Va., march by neo-Nazis and white supremacists.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • It looks like greed is a excellent motivator. His former outrage, was likely a publicity stunt, now he embraces racism, hate and ignorance. The Bending of the knee, will be really profitable. There is not much skepticism on here, since everyone involved but the patients, are seeing billion dollar jackpots.

  • Hold the presses!! “For the record, J&J did not respond to our questions.”
    Actually, not a surprise at all but ‘useful for the record.’ Now THE question, did young Alex repatriate enough … after taxes, of course … to cover that talcum powder judgment?

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy